Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Selby

Showing results (211-220 of 316) with videos related to

Pageof 32
Sort By:
Proteomics. Clinical Applications|December 8, 2010
Changes in the urinary proteome post-operatively in renal cancer patients - a reflection of tumour or kidney removal?Sheryl H Sim, David A Cairns, David N Perkins, et al.
British Journal of Cancer|March 2, 2013
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosisR I McCormick, C Blick, J Ragoussis, et al.
British Journal of Cancer|December 1, 1988
High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytomaE K Mbidde, P J Selby, T J Perren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
OK432-activated human dendritic cells kill tumor cells via CD40/CD40 ligand interactionsKaty S Hill, Fiona Errington, Lynette P Steele, et al.
European Urology Oncology|August 15, 2019
Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015Mehran Afshar, Hiten R H Patel, Maria De-Santis, et al.
Proteomics|April 6, 2006
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinomaRachel A Craven, Anthea J Stanley, Sarah Hanrahan, et al.
British Journal of Haematology|December 21, 2000
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescueA S Protheroe, C Pickard, P W Johnson, et al.
The Journal of Pathology|December 19, 2001
BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridizationR Achuthan, S M Bell, I M Carr, et al.
International Journal of Cancer|September 24, 2004
Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapySarah L Young, Michael Murphy, Xing Wu Zhu, et al.
The American Journal of Pathology|July 24, 2003
Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitorChristine P Diggle, Sheena Cruickshank, Jonathon D Olsburgh, et al.
Pageof 32

Showing results (211-220 of 316) with videos related to

Sort By:
Pageof 32
Proteomics. Clinical Applications|December 8, 2010
Changes in the urinary proteome post-operatively in renal cancer patients - a reflection of tumour or kidney removal?Sheryl H Sim, David A Cairns, David N Perkins, et al.
British Journal of Cancer|March 2, 2013
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosisR I McCormick, C Blick, J Ragoussis, et al.
British Journal of Cancer|December 1, 1988
High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytomaE K Mbidde, P J Selby, T J Perren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
OK432-activated human dendritic cells kill tumor cells via CD40/CD40 ligand interactionsKaty S Hill, Fiona Errington, Lynette P Steele, et al.
European Urology Oncology|August 15, 2019
Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015Mehran Afshar, Hiten R H Patel, Maria De-Santis, et al.
Proteomics|April 6, 2006
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinomaRachel A Craven, Anthea J Stanley, Sarah Hanrahan, et al.
British Journal of Haematology|December 21, 2000
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescueA S Protheroe, C Pickard, P W Johnson, et al.
The Journal of Pathology|December 19, 2001
BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridizationR Achuthan, S M Bell, I M Carr, et al.
International Journal of Cancer|September 24, 2004
Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapySarah L Young, Michael Murphy, Xing Wu Zhu, et al.
The American Journal of Pathology|July 24, 2003
Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitorChristine P Diggle, Sheena Cruickshank, Jonathon D Olsburgh, et al.
Pageof 32